A5032487705- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular Function and Risk Factors
- Hemodynamic Monitoring and Therapy
- Blood Pressure and Hypertension Studies
- Cardiac Imaging and Diagnostics
- Cardiovascular Disease and Adiposity
- Hip and Femur Fractures
- Ultrasound and Hyperthermia Applications
- Healthcare Regulation
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Education and Validation
- Nursing Diagnosis and Documentation
- Public Health in Brazil
- Neuroscience of respiration and sleep
- Cardiomyopathy and Myosin Studies
- Heart Rate Variability and Autonomic Control
- Sleep and related disorders
- Health and Lifestyle Studies
- Cardiovascular and exercise physiology
- Climate Change and Health Impacts
- Hormonal Regulation and Hypertension
- Airway Management and Intubation Techniques
- Elasticity and Material Modeling
- Aortic aneurysm repair treatments
- Cardiovascular and Diving-Related Complications
Universidade Federal do Rio Grande do Sul
2008-2020
Hospital de Clínicas de Porto Alegre
2007-2019
A large proportion of patients with hypertension need a second drug to reach satisfactory control blood pressure (BP), but there are few well-designed controlled trials comparing the efficacy drugs added as option. In double-blind randomized clinical trial, 82 uncontrolled BP, receiving hydrochlorothiazide 25 mg daily, were selected receive amiloride 2.5–5 mg/day (n = 39) or enalapril 10–20 43). Ambulatory monitoring (ABPM) was done before and after 12-weeks treatment. Office BP measured in...
Background . Cardiac troponin levels have been reported to add value in the detection of cardiovascular complications noncardiac surgery. A sensitive cardiac I (cTnI) assay could provide more accurate prognostic information. Methods This study prospectively enrolled 142 patients with at least one Revised Risk Index risk factor who underwent cTnI were measured postoperatively. Short-term outcome predictors evaluated. Results elevation was observed 47 patients, among whom 14 diagnosed as...
High blood pressure (BP) is associated with higher rates of cardiovascular events, even in stage I hypertension (HTN) and prehypertension (preHTN). Lower left ventricular (LV) systolic function, assessed by global longitudinal strain (GLS), has been demonstrated individuals HTN compared to normal BP, but a comparison preHTN was not described date. The PREVER study includes two randomized double-blind controlled trials, performed volunteers (PREVER-prevention trial) or (PREVER-treatment...
Antihypertensive treatment improves echocardiographic parameters of hypertensive target organ damage in stage II hypertension, but less is known about the effects I hypertension.In a cohort study nested randomized double-blind trial PREVER-treatment, 2-dimensional echocardiograms were performed 110 individuals, aged 54.8 ± 7.9 years-old, with hypertension at baseline and after 18 months chlorthalidone/amiloride or losartan.At baseline, 66 (60%) participants had concentric remodeling. After...
Preoperative NT-proBNP has been shown to predict adverse cardiac outcomes, although recent studies suggested that postoperative determination could provide additional information in patients submitted noncardiac surgery.To evaluate the prognostic value of perioperative intermediate and high risk cardiovascular undergoing surgery.This study prospectively enrolled 145 aged ≥ 45 years, with at least one Revised Cardiac Risk Index factor or surgery. levels were measured pre- postoperatively....
Blood pressure (BP)-lowering therapy improves left ventricular (LV) parameters of hypertensive target-organ damage in stage II hypertension, but whether there is a drug-class difference echocardiographic I hypertension patients less often studied. In the PREVER treatment study, where individuals with were randomized for diuretics (chlorthalidone/amiloride) or losartan, 110 participants accepted to participate sub-study, two-dimensional echocardiograms performed at baseline and after 18...